Antibody cocktail against SARS-CoV-2 spike protein
US11834493B2 · kind B2 · utility
0Cited by
5References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 4, 2022 |
| Grant date | Dec 5, 2023 |
| Priority date | — |
| Expiry date | Jan 4, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein are antibodies that are useful for treating SARS-CoV-2 infections in a subject. Also provided herein are compositions comprising one or more antibodies, methods of treatment comprising administering one or more antibodies, and kits comprising one or more antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.